#Sweden #Medical Devices #Malmö #Rosti Group #Alvi Group

Rosti Group Acquires Alvi Group: A Strategic Move in Medical Manufacturing

In an important development within the industrial sector, Rosti Group, a prominent player in plastic injection moulding and contract manufacturing, announced the acquisition of Alvi Group. This landmark deal took place on November 2, 2026, and serves to strengthen Rosti's footprint in the global market while enhancing its capabilities in medical device manufacturing.

Expansion of Operations

The acquisition integrates Alvi's five operational sites located in Leksvik (Norway), Tyresö (Sweden), Wrocław (Poland), and Suzhou (China), along with around 400 employees into the Rosti Group. This not only solidifies Rosti’s existing workforce but also increases its operational capacity and expertise in key markets. With Alvi’s addition, Rosti boasts approximately 3,000 employees and an impressive combined revenue of EUR 450 million, marking a significant leap from its prior figures.

Strengthening Medical Device Manufacturing

Jonas Persson, CEO of Rosti Group, expressed enthusiasm about the acquisition, emphasizing that this move significantly bolsters Rosti's operational capabilities in medical and industrial sectors across Europe and Asia. The integration allows Rosti to utilize Alvi's established practices and teams, driving further innovation and providing customers with enhanced support and offerings.

Alvi’s customers will now have access to Rosti's extensive global network, as well as engineering support, research and development, and innovation resources. This collaboration aligns customer interests with Rosti’s well-defined sustainability practices, ensuring that they can continue to receive high-quality services while adhering to corporate social responsibility norms.

Enhanced Customer Benefits

Magnus Emeus, CEO of Alvi Group, described Rosti as the ideal partner for Alvi’s operations and clients. “Our customers and teams stand to benefit from the robust resources and market presence that Rosti can provide,” he stated. As a result of the merger, customers will experience a seamless transition and gain access to a wider range of industrial and medical device contract manufacturing capabilities.

The operational sites previously known as Alvi now carry the Rosti name, rebranding them as Rosti Norway, Rosti Sweden, Rosti Poland, and Rosti China. This branding strategy reflects unity within the organization while signifying an enhanced commitment to quality and innovation in manufacturing.

Historical Context and Future Directions

Founded in 1944 and headquartered in Malmö, Sweden, Rosti Group has forged a reputation for delivering comprehensive plastic injection moulding solutions to major OEMs in medical, consumer, and industrial sectors. The addition of Alvi Group not only adds value to Rosti's existing offerings but also positions the organization favorably to achieve further growth in a competitive market landscape.

Looking forward, Rosti Group aims to leverage this acquisition to further broaden its geographic reach and capability spectrum, ensuring that it remains a key player in the global manufacturing arena. With a strong foundation and a commitment to excellence, Rosti is well-equipped to meet the evolving demands of its customers while spearheading innovation across its operational sectors.

Conclusion

The acquisition of Alvi Group by Rosti Group is a testament to the ongoing evolution within the manufacturing industry, particularly in the medical sector. As companies like Rosti continue to adapt and expand their capabilities, the focus on delivering high-quality and sustainable solutions remains more critical than ever. Stakeholders across the board can anticipate substantial benefits as Rosti and Alvi embark on this new chapter together.